Nifty Holds Marginal Gains as Markets Await Key Triggers Bond Yields Geopolitical Risks and FII Flows in Focus Rosen Law Firm Reminds SES AI Corporation Investors of Class Action Deadline Seeking Counsel Microsoft Names Jenny LayFlurrie as Trusted Technology Lead Balancing AI Speed with Responsible Development Carney Highlights Albertas Economic Importance Amid Separation Referendum Plans Bond Market Signals Concern as Fed May Fall Behind on Inflation Warsh Era Begins European AI Stocks Buck Broader Market Gloom Amid Heightened Geopolitical Risks Rush Street Interactive RSI Q1 2026 Earnings Profit Beat Lifts Sentiment Despite Stock Pullback 51Talk COE Q3 2025 Earnings Wider Loss Weighs on Shares as Revenue Details Remain Unclear JD Q1 2026 Earnings EPS Misses Estimates Stock Declines 3 Silicom Ltd SILC Q1 2026 Earnings EPS Beat Despite Loss Stock Rises on NarrowerThanExpected Loss Teledyne Technologies TDY Q1 2026 Earnings EPS Beat Drives Modest Stock Gain NAT Q4 2025 Earnings EPS Misses Estimates by 56 Amid Weak Tanker Market Graphic Packaging GPK Surges 388 as Stock Tests Key Resistance Near 1180 Tencent Music TME Holds Near 921 Support as Trading Volumes Suggest Cautious Optimism Nano Dimension NNDM Nears Support Amid Slight Decline Key Levels in Focus eXp World Holdings EXPI Holds Steady at 674 as Market Awaits Catalyst SolarEdge Technologies SEDG Slides 17 Amid Broader Solar Headwinds Key Support Levels Tested Chinas Humanoid Robot Ambitions Elon Musk Highlights Competitive Threat EVH Q1 2026 Earnings NarrowerthanExpected Loss Drives Stock Higher Lineage Cell Therapeutics LCTX Gains 3 as Biotech Sector Finds Support EHI Western Asset Global High Income Fund Edges Higher Holding Near Key Support Dune Acquisition Corporation II IPOD Holds Steady at 1042 SPAC Trading Near Trust Value FFIC Slips 075 as Investors Await Clearer Direction Huntington Bancshares Preferred HBANM Slips 087 as Support Levels Tested Reservoir Media Inc RSVR Holds Steady at 1020 as Consolidation Phase Continues Rapport Therapeutics RAPP Holds Steady as Minor Decline Tests Key Support Levels Palvella Therapeutics PVLA Slips 166 as Shares Test Key Support Levels